Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Wessely

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Current Oncology (Toronto, Ont.)|February 22, 2021
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic KeratosisAnja Wessely, Theresa Steeb, Franz Heppt, et al.
JMIR Mhealth and Uhealth|November 10, 2020
Patient Perception of Mobile Phone Apps for the Care and Prevention of Sexually Transmitted Diseases: Cross-Sectional StudyLena Jakob, Theresa Steeb, Zeno Fiocco, et al.
International Journal of Molecular Sciences|October 29, 2025
Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8Elias A T Koch, Renato Liguori, Alejandro Afonso Castro, et al.
International Journal of Molecular Sciences|January 21, 2022
HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and MelanomaMarkus V Heppt, Anja Wessely, Eva Hornig, et al.
Frontiers in Medicine|February 6, 2023
Conventional and three-dimensional photography as a tool to map distribution patterns of in-transit melanoma metastases on the lower extremityKilian Müller, Carola Berking, Caroline Voskens, et al.
Virchows Archiv : an International Journal of Pathology|September 25, 2025
An artificial intelligence model of whole-slide pathology specimens differentiating cutaneous high-grade squamous proliferationsAnne Petzold, Anja Wessely, Michael Erdmann, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2021
Clinical determinants of long-term survival in metastatic uveal melanomaElias A T Koch, Anne Petzold, Anja Wessely, et al.
Journal of Clinical Medicine|May 16, 2020
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional TrialTheresa Steeb, Anja Wessely, Dagmar von Bubnoff, et al.
Frontiers of Medicine|July 11, 2023
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trialElias A T Koch, Anne Petzold, Anja Wessely, et al.
Journal for Immunotherapy of Cancer|May 9, 2024
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapyChristopher Lischer, Martin Eberhardt, Cindy Flamann, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Current Oncology (Toronto, Ont.)|February 22, 2021
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic KeratosisAnja Wessely, Theresa Steeb, Franz Heppt, et al.
JMIR Mhealth and Uhealth|November 10, 2020
Patient Perception of Mobile Phone Apps for the Care and Prevention of Sexually Transmitted Diseases: Cross-Sectional StudyLena Jakob, Theresa Steeb, Zeno Fiocco, et al.
International Journal of Molecular Sciences|October 29, 2025
Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8Elias A T Koch, Renato Liguori, Alejandro Afonso Castro, et al.
International Journal of Molecular Sciences|January 21, 2022
HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and MelanomaMarkus V Heppt, Anja Wessely, Eva Hornig, et al.
Frontiers in Medicine|February 6, 2023
Conventional and three-dimensional photography as a tool to map distribution patterns of in-transit melanoma metastases on the lower extremityKilian Müller, Carola Berking, Caroline Voskens, et al.
Virchows Archiv : an International Journal of Pathology|September 25, 2025
An artificial intelligence model of whole-slide pathology specimens differentiating cutaneous high-grade squamous proliferationsAnne Petzold, Anja Wessely, Michael Erdmann, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2021
Clinical determinants of long-term survival in metastatic uveal melanomaElias A T Koch, Anne Petzold, Anja Wessely, et al.
Journal of Clinical Medicine|May 16, 2020
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional TrialTheresa Steeb, Anja Wessely, Dagmar von Bubnoff, et al.
Frontiers of Medicine|July 11, 2023
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trialElias A T Koch, Anne Petzold, Anja Wessely, et al.
Journal for Immunotherapy of Cancer|May 9, 2024
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapyChristopher Lischer, Martin Eberhardt, Cindy Flamann, et al.
Pageof 6